表紙
市場調査レポート

米国の心臓用医療機器市場:2016〜2020年

Cardiac Medical Devices Market in the US 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 353184
出版日 ページ情報 英文 71 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
米国の心臓用医療機器市場:2016〜2020年 Cardiac Medical Devices Market in the US 2016-2020
出版日: 2016年02月24日 ページ情報: 英文 71 Pages
概要

心房細動(AF)は不整脈の一般的タイプで、疾病対策センター(CDC)の2015年の予測によると、米国の270万〜610万人が心房細動と診断され、ペースメーカーや埋め込み型除細動器などの心臓用医療機器が用いられています。米国の心臓用医療機器市場は、2016〜2020年にかけCAG1.82%で拡大すると予測されています。

当レポートでは、米国の心臓用医療機器市場の現状と今後の成長見通し、市場動向、市場成長への課題、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

  • 市場ハイライト

第5章 米国における法規制と償還シナリオ

  • 心臓用医療機器埋め込みに関するMedicareによる平均価格

第6章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 製品別市場セグメンテーション

  • CRM装置
  • 米国におけるCRM装置市場
  • 心臓アシストデバイス
  • 米国における心臓アシストデバイス市場
  • 心臓弁
  • 米国における心臓弁市場

第8章 市場促進因子

  • 心臓疾患の罹患率
  • 心臓提供者の不足
  • 民衆の認識増加

第9章 促進因子の影響

第10章 市場の課題

  • 製品リコール
  • 心臓医療機器のコストの高さ
  • 法規制の複雑さ
  • 激しい競争
  • CRM装置による合併症

第11章 促進因子および課題の影響

第12章 市場動向

第13章 ベンダー環境

  • 競合シナリオ
  • 市場シェア分析
  • Boston Scientific
  • Medtronic
  • LivaNova
  • St. Jude Medical
  • その他の注目すべきベンダー

第14章 付録

第15章 Technavioについて

図表

目次
Product Code: IRTNTR8830

About Cardiac Medical Devices Market in the US

Atrial fibrillation (AF), a common type of heart arrhythmia, is a heart condition when the heart beats too fast or too slow or in an irregular way. An estimation done by the Centers for Disease Control and Prevention (CDC) in 2015 shows that in the US 2.7-6.1 million people were diagnosed with AF. It is most common in the older population, among people aged 60 years or above. This condition occurs when the heart's ability to function reduces and there is a malfunction in the electrical impulses in the heart, which leads to sudden cardiac arrest or heart failure.

Cardiac output such as an irregularity in the ventricular rate can lead to diastolic dysfunction. Hence, to reduce the risk of irregular heartbeat, especially for people that are at a higher risk of arrhythmia or have recurrent arrhythmia, cardiac medical devices such as pacemaker or implantable cardioverter defibrillators (ICD) are used to help the heart's electrical activity and heart rhythm function. These devices are small and are placed below the collar bone. Heart attacks can also cause defects in the heart valves, which can be replaced by mechanical or tissue heart valves.

Technavio's analysts forecast the cardiac medical devices market in the US to grow at a CAGR of 1.82% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the cardiac medical devices market in the US for 2016-2020. Cardiac medical devices that are included in this report are implanted in the heart through minimally invasive surgeries. To calculate the market size, the report considers the revenue generated from the sales of the products.

The market is divided into the following segments based on product type:

  • Cardiac rhythm management (CRM) devices
  • Cardiac assist devices
  • Heart valve

Technavio's report, Cardiac Medical Devices Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

Other Prominent Vendors

  • Abiomed
  • Adam, Rouilly
  • Advanced Instrumentations
  • A.M.I. ITALIA
  • Biotronik
  • Cardioline
  • Cardia International
  • Cardiac Science (subsidiary of Opto Circuits)
  • Colibri Heart Valve
  • Corpuls
  • Edwards Lifesciences
  • EMTEL
  • Fukuda Denshi
  • HeartWare
  • Innomed
  • INSTRAMED
  • MEDIANA
  • M&B Electronic Instruments
  • Medical ECONET
  • Mindray Medical
  • Physio Control
  • PRIMEDIC
  • Prestan
  • Schiller
  • Spectranetics
  • SynCardia
  • Symetis
  • TTK Healthcare
  • WNL Products

Market driver

  • Prevalence of cardiac disorders
  • For a full, detailed list, view our report

Market challenge

  • High cost of cardiac devices
  • For a full, detailed list, view our report

Market trend

  • Increase in M&A
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Product offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Regulation and reimbursement scenario in US

  • Average price provided by Medicare for cardiac medical device implantation

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product type

  • CRM devices
  • CRM devices market in US
  • Cardiac assist devices
  • Cardiac assist devices market in US
  • Heart valves
  • Heart valves market in US

PART 08: Market drivers

  • Prevalence of cardiac disorders
  • Shortage of heart donors
  • Increase in public awareness

PART 09: Impact of drivers

PART 10: Market challenges

  • Product recalls
  • High cost of cardiac devices
  • Regulatory complications
  • Intense competition
  • Complications of CRM devices

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Use of MRI in clinical applications
  • Popularity of robot-assisted surgery
  • Increase in M&A

PART 13: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • Boston Scientific
  • Medtronic
  • LivaNova
  • St. Jude Medical
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

PART 15: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Progression of heart failure due to AF
  • Exhibit 03: Types of cardiac medical devices
  • Exhibit 04: Snapshot of regulatory pathway for medical devices in US
  • Exhibit 05: Reimbursement scenario of cardiac medical devices in US
  • Exhibit 06: Cardiac medical devices market in US
  • Exhibit 07: Cardiac medical devices market in US 2015-2020 ($ billions)
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Segmentation of cardiac medical devices based on products
  • Exhibit 10: Cardiac medical devices market segmentation by product type 2015
  • Exhibit 11: Segmentation of CRM devices market by product type 2015
  • Exhibit 12: Segmentation of cardiac assist devices market by product type 2015
  • Exhibit 13: Segmentation of heart valves market by product type 2015
  • Exhibit 14: CRM devices market in US 2015-2020 ($ billions)
  • Exhibit 15: Cardiac assist devices market in US 2015-2020 ($ millions)
  • Exhibit 16: Heart valves market in US 2015-2020 ($ billions)
  • Exhibit 17: Impact of drivers
  • Exhibit 18: US FDA-initiated product recalls in 2013 and 2014
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Ranking of CRM vendors 2015
  • Exhibit 21: Ranking of cardiac assist devices vendors 2015
  • Exhibit 22: Ranking of heart valves vendors 2015
  • Exhibit 23: Boston Scientific: Business segmentation by revenue 2014
  • Exhibit 24: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 25: Boston Scientific: Geographical segmentation by revenue 2014
  • Exhibit 26: Boston Scientific: Key takeaways
  • Exhibit 27: Medtronic: Business segmentation by revenue 2015
  • Exhibit 28: Medtronic: Business segmentation by revenue 2014 and 2015 ($ billions)
  • Exhibit 29: Medtronic: Geographical segmentation by revenue 2015
  • Exhibit 30: Medtronic: Key takeaways
  • Exhibit 31: LivaNova: Business segmentation by revenue 2014
  • Exhibit 32: LivaNova: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 33: LivaNova: Key takeaways
  • Exhibit 34: St. Jude Medical: Business segmentation by revenue 2014
  • Exhibit 35: St. Jude Medical: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 36: St. Jude Medical: Key takeaways
Back to Top